Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cash And Cash Equivalents
$600 Mil (As of Dec. 2013)

Valeant Pharmaceuticals International Inc's quarterly cash and cash equivalents declined from Jun. 2013 ($2,539 Mil) to Sep. 2013 ($596 Mil) but then increased from Sep. 2013 ($596 Mil) to Dec. 2013 ($600 Mil).

Valeant Pharmaceuticals International Inc's annual cash and cash equivalents increased from Dec. 2011 ($164 Mil) to Dec. 2012 ($916 Mil) but then declined from Dec. 2012 ($916 Mil) to Dec. 2013 ($600 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 34445835434318114394164916600

Valeant Pharmaceuticals International Inc Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_CashAndCashEquivalents 2551643303952589164142,539596600
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide